Forecasting

Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics

Although the FDA is yet to present guidelines governing the social media space, pharma companies have started to adopt social media for research, marketing, communication, and stakeholder engagement. With these new endeavors come a raft of new responsibilities and tactical decisions managers must be prepared to make, not to mention vaults of data that, if handled appropriately, can reveal deep insights into a drug’s relationship with patients and prescribers. In this podcast, Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, explores the different ways pharma can use social media to effectively manage and analyze data.

To download a more comprehensive report on this topic, click here.

For more on social media, join the sector's other key players at KOL & Stakeholder Engagement Europe on Feb 21-Feb 22 in Berlin, SFE Europe and eMarketing Europe on March 27-29 in Barcelona, and SFE USA on May 30-31 in New Brunswick.

For exclusive business insights, download eyeforpharma's Pharma e-Marketing Strategy, Pharma Emerging Markets Report 2011-12 and Pharma Key Account Management Report 2011-12.

For all the latest business analysis and insight for the pharma industry, sign up to eyeforpharma’s newsletters and follow us on Twitter.